Clonal spread of both oxyimino-cephalosporin- and cefoxitin-resistant Klebsiella pneumoniae isolates co-producing SHV-2a and DHA-1 β-lactamase at a burns intensive care unit

International Journal of Antimicrobial Agents

Volumn 28, Issue 6, 2006, Pages 520-524

  Song, Wonkeun ^a,b   Lee, Kyu Man ^a   Kim, Han Sung ^a   Kim, Jae Seok ^a   Kim, Jonghyun ^a   Jeong, Seok Hoon ^c,d   Roh, Kyoung Ho ^b,d  

^a Hallym University College of Medicine   (South Korea)

^b Korea University College of Medicine   (South Korea)

^c Kosin University College of Medicine   (South Korea)

^d Yonsei University College of Medicine   (South Korea)

Author keywords

Clonal spread; Co production; DHA 1; Klebsiella pneumoniae; SHV 2a

Indexed keywords

AZTREONAM; BACTERIAL ENZYME; BETA LACTAMASE AMPC; CEFOXITIN; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; EXTENDED SPECTRUM BETA LACTAMASE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BURN PATIENT; CLONAL VARIATION; CONTROLLED STUDY; DILUTION; ENZYME ANALYSIS; ENZYME SYNTHESIS; GENE IDENTIFICATION; GENE INDUCTION; HOSPITAL PATIENT; INTENSIVE CARE UNIT; KLEBSIELLA PNEUMONIAE; LABORATORY TEST; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SEQUENCE ANALYSIS;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; BURN UNITS; CEFOXITIN; CEPHALOSPORIN RESISTANCE; CEPHALOSPORINS; DISEASE OUTBREAKS; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; KOREA; MICROBIAL SENSITIVITY TESTS; POLYMERASE CHAIN REACTION;

EID: 33751161052     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2006.07.019     Document Type: Article

References (24)

1. Bradford P.A. Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev 14 (2001) 933-951
2. Philippon A., Arlet G., and Jacoby G.A. Plasmid-determined AmpC-type β-lactamases. Antimicrob Agents Chemother 46 (2002) 1-11
3. Moland E.S., Black J.A., Ourada J., Reisbig M.D., Hanson N.D., and Thomson K.S. Occurrence of newer β-lactamases in Klebsiella pneumoniae isolates from 24 US hospitals. Antimicrob Agents Chemother 46 (2002) 3837-3842
4. Yong D., Lim Y., Song W., et al. Plasmid-mediated, inducible AmpC β-lactamase (DHA-1)-producing Enterobacteriaceae at a Korean hospital: wide dissemination in Klebsiella pneumoniae and Klebsiella oxytoca and emergence in Proteus mirabilis. Diagn Microbiol Infect Dis 53 (2005) 65-70
5. Song W., Kim J.S., Kim H.S., Park M.J., and Lee K.M. Appearance of Salmonella enterica isolates producing plasmid-mediated AmpC β-lactamase, CMY-2, in South Korea. Diagn Microbiol Infect Dis 52 (2005) 281-284
6. Thomson K.S. Controversies about extended-spectrum and AmpC beta-lactamases. Emerg Infect Dis 7 (2001) 333-336
7. Hanson N.D. AmpC beta-lactamases: what do we need to know for the future?. J Antimicrob Chemother 52 (2003) 2-4
8. Song W., Moland E.S., Hanson N.D., Lewis J.S., Jorgensen J.H., and Thomson K.S. Failure of cefepime therapy in treatment of Klebsiella pneumoniae bacteremia. J Clin Microbiol 43 (2005) 4891-4894
9. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 6th ed. Approved Standard M7-A6. Wayne, PA: NCCLS; 2003.
10. Brun-Buisson C., Legrand P., Philippon A., Montravers F., Ansquer M., and Duval J. Transferable enzymatic resistance to third-generation cephalosporins during nosocomial outbreak of multiresistant Klebsiella pneumoniae. Lancet ii (1987) 302-306
11. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Fifteenth informational supplement. M100-S15. Wayne, PA: CLSI; 2005.
12. Black J.A., Moland E.S., and Thomson K.S. AmpC disk test for detection of plasmid-mediated AmpC β-lactamases in Enterobacteriaceae lacking chromosomal AmpC β-lactamases. J Clin Microbiol 43 (2005) 3110-3113
13. Matthew W., Harris M., Marshall M.J., and Rose G.W. The use of analytical isoelectric focusing for detection and identification of β-lactamases. J Gen Microbiol 88 (1975) 169-178
14. Takahashi S., and Nagano Y. Rapid procedure for isolation of plasmid DNA and application to epidemiological analysis. J Clin Microbiol 20 (1984) 608-613
15. Perez-Perez F.J., and Hanson N.D. Detection of plasmid-mediated AmpC β-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol 40 (2002) 2153-2162
16. Song W., Kim J.S., Kim H.S., et al. Increasing trend in the prevalence of plasmid-mediated AmpC β-lactamases in Enterobacteriaceae lacking chromosomal ampC gene at a Korean university hospital from 2002 to 2004. Diagn Microbiol Infect Dis 55 (2006) 219-224
17. De Champs C., Sirot D., Chanal C., Bonnet R., and Sirot J. A 1998 survey of extended-spectrum β-lactamases in Enterobacteriaceae in France. Antimicrob Agents Chemother 44 (2000) 3177-3179
18. Jacoby G.A., Chow N., and Waites K.B. Prevalence of plasmid-mediated quinolone resistance. Antimicrob Agents Chemother 47 (2003) 559-562
19. Sambrook J., Fitsch E.F., and Maniatus T. Molecular cloning: a laboratory manual. 2nd ed. (1989), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
20. Jacoby G.A., and Han P. Detection of extended-spectrum β-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli. J Clin Microbiol 34 (1996) 908-911
21. Kim J., Kwon Y., Pai H., Kim J.W., and Cho D.T. Survey of Klebsiella pneumoniae strains producing extended-spectrum β-lactamases: prevalence of SHV-12 and SHV-2a in Korea. J Clin Microbiol 36 (1998) 1446-1449
22. Song W., Kim J.S., Kim H.S., Jeong S.H., Yong D., and Lee K.M. Emergence of Escherichia coli isolates producing conjugative plasmid-mediated DHA-1 β-lactamase in a Korean university hospital. J Hosp Infect 63 (2006) 458-463
23. SHV-5 in a French university hospital. J Antimicrob Chemother 57 (2006) 142-145
24. Yan J.J., Ko W.C., Wu H.M., Tsai S.H., Chuang C.L., and Wu J.J. Complexity of Klebsiella pneumoniae isolates resistant to both cephamycins and extended-spectrum cephalosporins at a teaching hospital in Taiwan. J Clin Microbiol 42 (2004) 5337-5340